Task: Answer the multiple choice question.
Query: Which drug exhibits a 30.062% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1ccc(CCN(C)C(=O)c2cncc(Br)c2)cc1OC
b: CCc1noc(C)c1C(=O)N1CCCSC1=Nc1ccccc1Cl
Answer: a. COc1ccc(CCN(C)C(=O)c2cncc(Br)c2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCN(C)C(=O)c2cncc(Br)c2)cc1OC
COc1ccc(CCN(C)C(=O)c2cncc(Br)c2)cc1OC
5-bromo-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylpyridine-3-carboxamide